D
Daniela Ribita
Researcher at Glenn Research Center
Publications - 3
Citations - 117
Daniela Ribita is an academic researcher from Glenn Research Center. The author has contributed to research in topics: Angiogenesis. The author has an hindex of 2, co-authored 3 publications receiving 109 citations.
Papers
More filters
Journal ArticleDOI
VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks
Mary B. Vickerman,Patricia A. Keith,Terri L. McKay,Dan J. Gedeon,Michiko Watanabe,Monica M. Montano,Ganga Karunamuni,Peter K. Kaiser,Jonathan E. Sears,Quteba Ebrahem,Daniela Ribita,Alan Hylton,Patricia Parsons-Wingerter +12 more
TL;DR: Application of VESGEN 2D to angiogenic and lymphangiogenic tissues that includes the human and murine retina, embryonic coronary vessels, and avian chorioallantoic membrane is reviewed.
Journal ArticleDOI
Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide.
Terri L. McKay,Dan J. Gedeon,Mary B. Vickerman,Alan Hylton,Daniela Ribita,Harry H. Olar,Peter K. Kaiser,Patricia Parsons-Wingerter +7 more
TL;DR: By VESGEN analysis, TA selectively inhibited the angiogenesis of smaller blood vessels, but decreased the vessel diameter of all vessels within the vascular tree.
Triamcinolone Acetonide Selectively Inhibits Angiogenesis in Small Blood Vessels and Decreases Vessel Diameter within the Vascular Tree
Terri L. McKay,Dan J. Gredeon,Mary B. Vickerman,Alan Hylton,Daniela Ribita,Harry H. Olar,Peter K. Kaiser,Patricia Parsons-Wingerter +7 more
TL;DR: The steroid triamcinolone acetonide (TA) is a potent anti-angiogenesis drug used to treat retinal vascular diseases that include diabetic retinopathy, vascular occlusions and choroidal neovascularization to quantify the effects of TA on branching morphology within the angiogenic microvascular tree of the chorioallantoic membrane of quail embryos.